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HypothesisAbstract Radiation induced injury is a limiting factor in radiation related approaches from earth
to space. Inductions of a wide spectrum of damages in radiotherapy patients due to unwanted nor-
mal tissues irradiation and space radiation related diseases in astronauts have been caused many
limitations in cancer treatment and space missions. There are many radiation protection/mitigation
approaches including: physical, chemical, biological and physiological methods. Radiation protec-
tion using these methods is expensive and also has many problems including acute toxicities and
difﬁculties in their targeting to normal tissues. Based on experimental and hypothetical data, show-
ing that medical/biological gases have many protective effects such as antioxidant, anti-inﬂamma-
tory, anti-apoptotic, and induction of radioresistance, we hypothesize that similar gases which have
been produced by microorganisms (biogases) have those properties and may be used as radiation
mitigators/protectors in radiation related approaches such as radiotherapy, radiation accidents
and in space missions. Isolation microorganism in safe laboratory conditions in enough amounts,
ﬁnding non-toxic dose of microorganisms that provide highest radioprotection percent, dose reduc-
tion factor (DRF) calculation to compare the radioprotective efﬁcacy of the microorganisms, ﬁnd-
ing the best targeting techniques to deliver those microorganisms into normal tissues, genetically
manipulations of microorganism to achieve the highest amount of biogases with lowest side effects
can be done for testing the hypothesis.
ª 2015 Tehran University of Medical Sciences. Published by Elsevier Ltd. This is an open access article
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).862247,
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Radiation injuries and radioprotectors
Radiation induced injury is a limiting factor in radiation
related approaches from earth to space. Inductions of a wide
spectrum of damages in radiotherapy patients due to
unwanted normal tissues irradiation and space radiation
related diseases in astronauts have been caused many limita-
tions in cancer treatment and space missions [1–4].
Developments of radiation related damages have led to the
conclusion that radiation can result in diminished quality of
life and carries the potential for severe debilitating disease.
In radiotherapy, the mechanism of normal tissues injury is
very complex and based on dose, manifestation time, volume
of irradiated tissue and radiosensitivity can be categorized as
acute and late injuries. Speaking generally, interaction of low
LET ionizing radiation with normal tissues results in forma-
tion of free radicals such as reactive oxygen/nitrogen species
(ROS/RNS) that cause oxidative stress and activation of some
transcription factors, pro-inﬂammatory molecules and cyto-
toxicity by inducing DNA damage, alteration of cell func-
tion/phenotype, resulting in chronic inﬂammation, organ
dysfunction, and ultimate ﬁbrosis and/or necrosis [5,6] (Fig. 1).
In the other hand, radiation environment in space is very
unique and complex and has three components including:
galactic cosmic radiation (GCR), solar particle events (SPE)
and trapped energetic particles (TEP). The high LET/charge/
energy particles such as protons and Helium from GCR can
cause more complex biological effects. In addition to cardio-
vascular, CNS, hematopoietic and many other diseases, recent
evidence show, GCR leads to cognitive impairment and
increased Ab plaque accumulation and so Alzheimer’s disease
[7–9].
There are different radiation protection/mitigation
approaches including: physical, chemical, biological and phys-
iological based methods. The physical approaches such asFig. 1 Putative pathways of chronic oxidative stress resulting in
the radiation-induced late effects. Adapted from Zhao et al. with
permission (Ref [5]).shielding and technological enhanced radiation delivery is
more prominent and new radiotherapy devices and techniques
have been developed to have less normal tissue injuries, but
those techniques are expensive and have their own problems.
In space also, GCR and SPE can penetrate into the shielding
material of planet and produce secondary radiation, including
neutrons, gamma rays and other radiations. So, additional
shielding is required.
In the other hand, many biological and chemical radiation
protection/mitigation were suggested. Radioadaptive response
by ionizing and non-ionizing radiofrequency radiation [10–12],
natural radioprotector agents [13,14], antioxidants materials
[15,16], immunomodulatory agents [17,18] and many others
were tested and hypothesized as useful radiation counterbal-
ancing tricks [19–23].
In recent years, there has been a hypothetical focus on med-
ical gases as radiation protection agents. In an interesting
paper, Schoenfeld et al hypothesized that ‘‘hydrogen adminis-
tration to the astronauts by either inhalation or drinking
hydrogen-rich water may potentially yield a novel and feasible
preventative/therapeutic strategy to prevent radiation-induced
adverse events’’ [24]. Liu et al also hypothesized that hydrogen
therapy may be an effective and speciﬁc novel treatment for
acute radiation syndrome [25]. The main proposed mecha-
nisms of hydrogen are increase in antioxidant enzymes and
reducing free radicals.
In continuing to their hypothetical works, Schoenfeld et al,
by reviewing the radiolysis properties of water, biological
effects of gas, and radiobiological mechanisms, suggested a
systems biology approach that proposed medical gases includ-
ing CO, H2, NO, and H2S as chemical radioprotectors for
radical scavenging and as biological signaling molecules for
management of the body’s response to exposure [26].
According to this paper, medical gases have many beneﬁcial
properties such as: radical scavenging, anti-apoptotic, anti-in-
ﬂammatory and they also can decrease radiosensitivity. We
showed the main radiation protection mechanisms of these
gases in Fig. 2 brieﬂy.Medical 
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Anti-apoptotic
Metabolic 
alteration
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RadioresistanceAntioxidant 
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Fig. 2 The main radiation protection mechanisms of medical
gases.
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It is well established that many microorganisms such as bacte-
ria and archaea produce various gases (biogases) by different
mechanisms [27–30]. There are different biogases including:
Oxygen (O2), hydrogen (H2), nitric oxide (NO), carbon
monoxide (CO), and hydrogen sulﬁde (H2S). Biogases have
complex roles in signal transduction and modulating physio-
logical function based on their rate of production, concentra-
tion, chemical reactivity, and availability of target proteins
[31].
Biological mechanisms of biogases (here we called them
BIONO, BIOH2, BIOCO & BIOH2S) production are not yet
fully understood but they occur via a variety of microbial
metabolisms, reductive and oxidative processes, biophotolysis,
photofermentation, dark fermentation and different unproved
mechanisms.The hypothesis
Based on experimental and hypothetical data, showing that
medical/biological gases have many protective effects such as
antioxidant, anti-inﬂammatory, anti-apoptotic, and induction
of radioresistance, we hypothesize that similar gases which
have been produced by microorganisms (biogases) have those
properties and may be used as radiation mitigators/protectors
in radiation related approaches such as radiotherapy, radiation
accidents and in space missions.
This hypothesis is based on the following items: 1) ﬁnding
the main microorganisms that produce biogas, 2) production
of biogas in well enough amounts, 3) biosafety of microorgan-
isms and their products, 4) ﬁnding the best route of adminis-
tration 5) targeting the microorganisms in normal tissues in
radiotherapy and 6) genetic manipulation of those microor-
ganisms for high efﬁciency.
In regard to item four, route of administration is dependent
on sites that biogas should be used. For example, if the treat-
ment site is GI tract, oral, buccal, and rectal administration
may be feasible approaches. Also for other sites, targeting
microorganisms can be done. The other remedial approach is
to earn and separate bacteria from different sites of human
body and do an individualized care. For example, we can sep-
arate a speciﬁc bacteria from a person GI tract and did any
required modiﬁcation on bacteria and again sent into the GI
tract.
Also we suggest the following methods to deliver and
administrate of bacteria into human body with low
immunogenicity:
 Bioengineered bacterial outer membrane vesicles (OMVs)
with low immunogenicity [32] that can produce biogas
and also deliver biogas to the target. In regard to OMVs,
the size of biogas producing bacteria should be smaller than
OMVs.
 PEGylation: PEGylation deﬁnes the modiﬁcation of a
molecule by the linking of one or more polyethylene glycol
(PEG) chains [33]. By PEGylation, we can delivered many
biogas producing bacteria via IV route. Transdermal delivery using laser, ultrasound, radiofre-
quency radiation and electroporation [34]. Bacteria can be
delivered via these approaches by loading them in a coating
material.
 Exosomes: Exosomes are a class of secreted membrane vesi-
cles that carry proteins and RNAs for intercellular commu-
nication [35]. They are increasingly seen as drug delivery
vehicles that deliver their cargo across the plasma mem-
brane and provide a barrier against premature transforma-
tion and elimination. For example human mesenchymal
stem cells as the ideal and immunologically inert source of
exosomes for drug delivery.
Evaluation of the hypothesis
We recommend the following research directions to test the
hypothesis:
1. Isolation and preparation of microorganism in safe labora-
tory conditions in enough amounts. Irradiation of microor-
ganisms can be used as a powerful approach for enriching
biogas-producing bacteria.
2. Performing different invivo and animal studies for ﬁnding
non-toxic dose of microorganisms that provide highest
radioprotection.
3. Injection and targeting of microorganisms into animal bod-
ies, then irradiation of animals by a lethal dose (e.g. LD50/
30; the dose of radiation expected to cause death to 50% of
an exposed population within 30 days), comparing survival
fraction (%) of irradiated groups to control groups. Dose
reduction factor (DRF) can be calculated to compare the
radioprotective efﬁcacy of the microorganisms.
4. Performing further molecular and cellular investigations to
ﬁnd the best pathways and mechanisms of radiation protec-
tion of biogases.
5. Finding the best targeting techniques to deliver those
microorganisms into normal tissues. Nanotechnology or
cell based drug delivery may be applied.
6. Genetically manipulations of microorganism to achieve the
highest amount of biogases with lowest side effects.
Discussion
Radiation protection using different radioprotectors has sev-
eral problems such as toxicity and targeting. Also, develop-
ment of new radioprotectors is dependent on enhanced
understanding of the molecular mechanisms associated with
the development of radiation induced injuries. In this paper
we introduced new classes of radioprotectors as ‘‘gas produc-
ing microorganism’’. A complex microbiological process by
many different microorganisms can result to production of
biogas, so, knowledge of the microbiology behind the biogas
process and microorganisms’ functions are required. It is indi-
cated that gas producing organisms have to work closely
together and disturbances of this teamwork results in reduced
production and breakdown of the biogases [36].
70 H. Abdollahi et al.The main properties of biogas as radioprotector are:
anti-apoptosis, antioxidants, and anti-inﬂammation and
radioresistance reductions. There are several reports indicating
gas producing bacteria in human bodies act as anti-cancer
agents [37–39]. For example Murata et al. showed H2S, a com-
mon metabolite of anaerobic oral bacteria, is an anticancer
compound that may contribute to the low incidence of oral
cancer [40]. Therefore these microorganisms can act as radio-
protectors and also as primary and secondary cancer preven-
tion agents. Targeting these agents into normal tissues
during radiotherapy may enhance the outcome of treatment
and lower normal tissue damages.
One of the main issues regarding this hypothesis is the
biosafety of gas producing microorganisms. It is should
emphasized that there are many microorganisms such that
are available in the human body, but it is important to ensure
that those microorganisms not contain pathogens that can
damage human tissues. Pretreatment of these living systems
with technological techniques is required to have lowest
pathology during and after consumption or injection of these
organisms.
Most of the gas producing bacteria are best ﬁt for
anaerobic conditions. But, human body have sufﬁcient
amount of oxygen, in this aerobic environment, we
recommend to use of aerobic bacteria or bacteria which
are live in both environment (presence or absence of oxygen)
to produce biogas. There are many aerobic bacteria that are
able to produce biogas such as H2S, NO and CO2. We can
use these bacteria for radiation protection. For example,
Escherichia coli is a bacterium that can grow in the absence
and presence of oxygen [41]. Also reprogramming of
anaerobic bacteria to grow, live and do their action in
aerobic condition. This can be done by bioengineering and
genetically modiﬁcation.
It should be mentioned that the suggested microorgan-
isms (e.g. bacteria) for biogas production, are in adaptation
with immune system and their residence in the body don’t
threat the human health. But, microorganism’s lifetime var-
ies by type and is dependent to many factors such as repro-
ductive capacity, environment, nutrients and conditions they
needs. Also, we can do genetically modiﬁcation of microor-
ganisms to do their acts in a well-established behavior such
as the well enough biogas production, suitable residence
time and best generation (cell cycle) time. Another way is
to use antibiotics.
The interesting part of this therapy is genetically manipula-
tion of those microorganisms. Biotechno-Microbiological
(BIOMIC) studies associated to genetic knowledge can help
researchers to ﬁnd best microorganisms with highest gas efﬁ-
ciency and lowest side effects and also their targeting to place
of treatment.Conclusion
In conclusion, biological gases which produced by microor-
ganism can be used as radioprotectors and also anticancer
agents. Further invivo studies are warranted to apply this ther-
apy in radiation related approaches.Overview Box
First Question: What do we already know about the
subject?
Radiation exposure can induce wide spectrum of dis-
eases in radiation related approaches from earth to space.
Radiation protection using different radioprotectors has
many problems including acute toxicities and difﬁculties
in their targeting to normal tissues.
Second Question: What does your proposed theory add
to the current knowledge available, and what beneﬁts does
it have?
This hypothesis introduces gas producing microorgan-
isms that might be able to improve radiotherapy outcome
and also save astronauts in space missions. The biogases
can act as antioxidants, anti-inﬂammation, anti-apoptosis
agents. They also can decrease radiosensitivity.
Third Question: Among numerous available studies,
what special further study is proposed for testing the idea?
Isolation microorganism in safe laboratory conditions
in enough amounts, ﬁnding the best non-toxic dose of
microorganisms, ﬁnding the best targeting techniques to
deliver those microorganisms into normal tissues, geneti-
cally manipulations of microorganism to achieve the high-
est amount of biogases with lowest side effects can be
done for testing the hypothesis.Conﬂict of interest
The authors declare that they have no conﬂict of interest.
References
[1] Kennedy AR. Biological effects of space radiation and
development of effective countermeasures. Life Sci Space Res
2014;1:10–43.
[2] Durante M. Space radiation protection: destination Mars. Life
Sci Space Res 2014;1:2–9.
[3] Moding EJ, Kastan MB, Kirsch DG. Strategies for optimizing
the response of cancer and normal tissues to radiation. Nat Rev
Drug Discov 2013;12:526–42.
[4] Begg AC, Stewart FA, Vens C. Strategies to improve
radiotherapy with targeted drugs. Nat Rev Cancer
2011;11:239–53.
[5] Zhao W, Diz D, Robbins M. Oxidative damage pathways in
relation to normal tissue injury. Br J Radiol 2007;80:23–31.
[6] Brush J, Lipnick SL, Phillips T, Sitko J, McDonald JT, McBride
WH. Molecular mechanisms of late normal tissue injury. Semin
Radiat Oncol 2007;17:121–30.
[7] Cucinotta FA. Space radiation risks for astronauts on multiple
international space station missions. PLoS One 2014;9:e96099.
[8] Begum N, Wang B, Mori M, Vares G. Does ionizing radiation
inﬂuence Alzheimer’s disease risk? J Radiat Res 2012
Nov;1(53):815–22.
[9] Cucinotta FA, Kim M-HY, Chappell LJ, Huff JL. How safe is
safe enough? Radiation risk for a human mission to Mars. PLoS
One 2013;8:e74988.
The potential use of biogas producing microorganisms in radiation protection 71[10] Abdollahi H, Teymouri M, Khademi S. Radiofrequency
radiation may help astronauts in space missions. J Med
Hypotheses Ideas 2012;6:66–9.
[11] Mortazavi S, Motamedifar M, Namdari G, Taheri M,
Mortazavi A. Counterbalancing immunosuppression-induced
infections during long-term stay of humans in space. J Med
Hypotheses Ideas 2013;7:8–10.
[12] Mortazavi S, Cameron J, Niroomand-Rad A. Adaptive
response studies may help choose astronauts for long-term
space travel. Adv Space Res 2003;31:1543–51.
[13] Maurya DK, Devasagayam TP, Nair CKK. Some novel
approaches for radioprotection and the beneﬁcial effect of
natural products. Indian J Exp Biol 2006;44:93.
[14] Hosseinimehr SJ. Beneﬁcial effects of natural products
on cells during ionizing radiation. Rev Environ Health 2014
Apr 2.
[15] Weiss JF, Landauer MR. Radioprotection by antioxidants. Ann
NY Acad Sci 2000;899:44–60.
[16] Bernal AJ, Dolinoy DC, Huang D, Skaar DA, Weinhouse C,
Jirtle RL. Adaptive radiation-induced epigenetic alterations
mitigated by antioxidants. FASEB J 2013;27:665–71.
[17] Hanash AM, Dudakov JA, Hua G, O’Connor MH, Young LF,
Singer NV, et al. Interleukin-22 protects intestinal stem cells
from immune-mediated tissue damage and regulates sensitivity
to graft versus host disease. Immunity 2012;37:339–50.
[18] Byrne SN, Beaugie C, O’Sullivan C, Leighton S, Halliday GM.
The immune-modulating cytokine and endogenous Alarmin
interleukin-33 is upregulated in skin exposed to inﬂammatory
UVB radiation. Am J Pathol 2011;179:211–22.
[19] Koukourakis M. Radiation damage and radioprotectants: new
concepts in the era of molecular medicine. Br J Radiol
2012;85:313–30.
[20] Citrin D, Cotrim AP, Hyodo F, Baum BJ, Krishna MC,
Mitchell JB. Radioprotectors and mitigators of radiation-
induced normal tissue injury. Oncologist 2010;15:360–71.
[21] Abdollahi H. Probiotic-based protection of normal tissues
during radiotherapy. Nutrition 2014;30:495.
[22] Khademi S, Abdollahi H. Application of hydrogen producing
microorganisms in radiotherapy: an idea. Iran J Pub Health
2014;43:1018–9.
[23] Abdollahi H. Beneﬁcial effects of cellular autoﬂuorescence
following ionization radiation: hypothetical approaches for
radiation protection and enhancing radiotherapy effectiveness.
Med Hypotheses 2015;84(3):194–8.
[24] Schoenfeld MP, Ansari RR, Zakrajsek JF, Billiar TR, Toyoda
Y, Wink DA, et al. Hydrogen therapy may reduce the risks
related to radiation-induced oxidative stress in space ﬂight. Med
Hypotheses 2011;76:117–8.[25] Liu C, Cui J, Sun Q, Cai J. Hydrogen therapy may be an
effective and speciﬁc novel treatment for acute radiation
syndrome. Med Hypotheses 2010;74:145–6.
[26] Schoenfeld MP, Ansari RR, Nakao A, Wink D. A hypothesis on
biological protection from space radiation through the use of
new therapeutic gases as medical counter measures. Med Gas
Res 2012;2:1–13.
[27] Weiland P. Biogas production: current state and perspectives.
Appl Microbiol Biotech 2010;85:849–60.
[28] Pimentel M, Mathur R, Chang C. Gas and the microbiome.
Curr Gastroenterol Rep 2013;15:1–6.
[29] Krishna RH. Review of research on production methods of
hydrogen: future fuel. Eur J Biotech Biosci 2013;1:84–93.
[30] Nandi R, Sengupta S. Microbial production of hydrogen: an
overview. Crit Rev Microbiol 1998;24:61–84.
[31] Yoshikawa T, Naito Y. Gas biology research in clinical
practice. Karger Medical and Scientiﬁc Publishers; 2011.
[32] Gujrati V, Kim S, Kim JJ, Min S, Choy HE, Kim SE, et al.
Bioengineered bacterial outer membrane vesicles as cell-speciﬁc
drug-delivery vehicles for cancer therapy. ACS Nano 2014 Feb
25;8(2):1525–37.
[33] Veronese FM, Pasut G. PEGylation, successful approach to
drug delivery. Drug Discov Today 2005 Nov 1;10(21):1451–8.
[34] Azagury A, Khoury L, Enden G, Kost J. Ultrasound mediated
transdermal drug delivery. Adv Drug Deliv Rev
2014;72(21):127–43.
[35] Lai RC, Yeo RW, Tan KH, Lim SK. Exosomes for drug
delivery – a novel application for the mesenchymal stem cell.
Biotechnol Adv 2013(5):543–51.
[36] Schnurer A, Jarvis A. Microbiological handbook for biogas
plants. Swedish Waste Management U 2010;2009:1–74.
[37] Murata T, Yaegaki K, Qian W, Herai M, Calenic B, Imai T,
et al. Hydrogen sulﬁde induces apoptosis in epithelial cells
derived from human gingiva. J Breath Res 2008;2:017007.
[38] Huang C-S, Kawamura T, Toyoda Y, Nakao A. Recent
advances in hydrogen research as a therapeutic medical gas.
Free Radic Res 2010;44:971–82.
[39] Williamson NR, Fineran PC, Gristwood T, Chawrai SR, Leeper
FJ, Salmond GP. Anticancer and immunosuppressive properties
of bacterial prodiginines. Future Microbiol 2007;2:605–18.
[40] Murata T, Hanada N. Anti-cancer effect of hydrogen sulﬁde: an
example of host-bacterial mutualism in oral cancer. Cancer Cell
Microenviron 2014:163. http://dx.doi.org/10.14800/ccm.
[41] Trotter EW, Rolfe MD, Hounslow AM, Craven CJ, Williamson
MP, Sanguinetti G, Poole RK, Green J. Reprogramming of
Escherichia coli K-12 metabolism during the initial phase of
transition from an anaerobic to a micro-aerobic environment.
PLoS One 2011;6(9):e25501.
